Product Description for PHLPP2
anti PHLPP2.
Properties: (C-term) Control Peptide
Properties: (C-term) Control Peptide
Properties for PHLPP2
| Product Category | Control Peptides |
|---|---|
| Target Category | |
| Quantity | 50 µg |
| Synonyms | KIAA0931, PH domain leucine-rich repeat-containing protein phosphatase 2, PH domain leucine-rich repeat-containing protein phosphatase-like, PHLPP-like, PHLPPL |
| Shipping to | Worldwide |
| PDF datasheet | View Datasheet |
| Manufacturer | OriGene Technologies GmbH |
| Material safety datasheet | MSDS for Polyclonal Antibodies (de) |
Datasheet Extract
| Immunogen |
|
|---|---|
| Property | C-term |
| Application | PHLPP2 peptide is used for blocking the activity of PHLPP2. |
| Concentration | 0.2 mg/ml |
| General Readings | Gao T, Furnari F and Newton AC. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 2005; 18:13–24. |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| Format |
|
| Specificity |
|
